Modern Fertility Treatments: What’s New in 2026? |Advanced Fertility Treatment in Bhandup – Dr. Sachin Dalal
Fertility treatment has become increasingly personalised, precise and patient-focused. Instead of recommending the same procedure to every couple, fertility specialists now use medical history, age, ovarian reserve, semen analysis, imaging and other investigations to identify the most appropriate approach.
In 2026, progress in assisted reproductive technology is largely centred on better diagnostics, individualised ovarian stimulation, improved laboratory practices, embryo assessment, cryopreservation and fertility preservation. Artificial intelligence is also being studied for supporting—not replacing—clinical and embryology decisions.
Explore advanced fertility treatment in Bhandup with personalised evaluation and guidance on IUI, IVF, ICSI and modern reproductive care.
What Is Infertility?
Infertility is generally defined as the inability to achieve pregnancy after 12 months or more of regular, unprotected sexual intercourse. It can result from female factors, male factors, a combination of both or causes that remain unexplained after standard evaluation. The World Health Organization recognises infertility as a condition of the male or female reproductive system.
Female infertility may be associated with ovulation disorders, blocked fallopian tubes, endometriosis, uterine abnormalities, fibroids, PCOS or hormonal problems. Male infertility may involve low sperm count, reduced motility, abnormal sperm morphology, hormonal conditions or reproductive-tract obstruction.
Because both partners may contribute to difficulty conceiving, a comprehensive evaluation should usually consider the couple together.
1. More Personalised Fertility Treatment Plans
Personalised fertility treatment means selecting a plan according to the individual needs of each patient or couple. Fertility specialists consider factors such as age, ovarian reserve, menstrual cycle, medical history, semen-analysis findings, previous pregnancies and responses to earlier treatments. Based on these findings, the doctor may recommend lifestyle guidance, ovulation induction, IUI, IVF, ICSI or another suitable option. This targeted approach can help avoid unnecessary procedures and ensure that treatment addresses the specific factors affecting conception. However, the response and outcome can still differ among patients.
2. Improved Ovarian Stimulation Strategies
Ovarian stimulation is an important part of many IVF cycles. Fertility specialists use hormonal medicines to encourage the development of multiple follicles before retrieving mature eggs.
Modern protocols focus on selecting medication and dosage according to the patient’s ovarian reserve, age, body characteristics and previous response. The goal is to obtain a suitable response while reducing avoidable risks.
The updated ESHRE guidance on ovarian stimulation emphasises evidence-based, individualised decisions rather than a single standard protocol for every patient. ESHRE Guidelines
Patients with a low ovarian reserve or a high predicted response may require different monitoring and treatment strategies. Regular ultrasound examinations and hormone testing help the doctor evaluate follicular development and adjust the plan when necessary.
3. Advanced Embryo Culture and Assessment
Embryos created during IVF are observed in a specialised laboratory before an embryo is selected for transfer or freezing. Embryologists traditionally assess development according to factors such as cell division, fragmentation and blastocyst appearance.
In 2026, clinics are increasingly focusing on standardised embryo morphology assessment and carefully controlled laboratory conditions. ESHRE lists updated guidance concerning IVF laboratory practice and oocyte and embryo morphology assessment among its current reproductive-medicine resources.
Better assessment can support embryo-ranking decisions, but appearance alone cannot guarantee implantation or predict the birth of a healthy baby.
4. Time-Lapse Embryo Monitoring
Time-lapse systems allow embryos to remain inside a controlled incubator while cameras capture images at regular intervals. This gives embryologists additional information about the timing and pattern of embryo development without repeatedly removing embryos for observation.
Although time-lapse monitoring provides useful laboratory information, patients should not assume that every technological add-on automatically increases the chance of a live birth. Its usefulness depends on the patient, laboratory practices and evidence supporting the particular system.
5. Artificial Intelligence in Fertility Care
Artificial intelligence is being researched for embryo image analysis, treatment-response prediction, workflow management and clinical decision support. AI systems may help analyse large amounts of data and identify patterns that are difficult to recognise consistently through manual assessment alone.
However, AI-assisted embryo evaluation remains an evolving field. The 2026 ESHRE scientific programme includes research and discussion on AI-based embryo and oocyte assessment, demonstrating that it remains an active area of investigation rather than a universal replacement for specialist judgement.
AI should support qualified fertility specialists and embryologists. Patients should be cautious about advertisements that promise guaranteed success based on an algorithm.
6. Improved Egg, Sperm and Embryo Freezing
Modern cryopreservation techniques have improved the way eggs, sperm and embryos are stored for future use. Vitrification, an ultra-rapid freezing method, reduces the formation of damaging ice crystals and is widely used for eggs and embryos. Freezing may benefit people who want to preserve reproductive options, patients preparing for medical treatments that could affect fertility and couples who have additional suitable embryos after IVF. Although modern freezing can preserve reproductive material effectively, it cannot guarantee a future pregnancy. Age at the time of freezing, the number and quality of stored cells or embryos, and future health remain important.
7. Expanding Fertility-Preservation Options
Fertility preservation is becoming an important part of reproductive and medical care. Depending on the person’s age, diagnosis and available time, options may include egg freezing, sperm freezing, embryo freezing and, in selected circumstances, ovarian- or testicular-tissue preservation. These options may be considered before chemotherapy, radiotherapy or surgery that could affect reproductive function. They may also be discussed with people who plan to delay parenthood. Early consultation is essential because fertility-preservation procedures are often more useful when completed before reproductive function is significantly affected.
8. Preimplantation Genetic Testing
Preimplantation genetic testing, or PGT, is performed during an IVF cycle to examine cells taken from an embryo before transfer. Different forms of PGT may be used to check for a known single-gene disorder, structural chromosome rearrangement or certain chromosome-number abnormalities. It may be considered for selected couples based on their genetic history, age, previous pregnancies or treatment history. PGT is not necessary for every IVF patient, and it does not guarantee implantation, pregnancy or the birth of a healthy baby. Genetic counselling helps couples understand the test’s purpose, limitations and possible results.
9. ICSI and Advanced Male-Fertility Care
Intracytoplasmic sperm injection, or ICSI, involves injecting a single sperm directly into an egg. It may be recommended in certain cases involving male-factor infertility, previous fertilisation problems or surgically retrieved sperm.
Modern male-fertility evaluation may include detailed semen analysis, physical assessment, hormonal testing and targeted investigations when clinically indicated.
ICSI is a valuable technique, but it is not automatically necessary in every IVF cycle. Its use should be based on the diagnosis and the couple’s treatment history.
10. Minimally Invasive Evaluation and Treatment
Some fertility problems are associated with uterine polyps, fibroids, adhesions, endometriosis or tubal conditions. Ultrasound, hysteroscopy and laparoscopy may help evaluate or treat specific problems when indicated.
Minimally invasive procedures generally use smaller instruments and may offer shorter recovery than traditional open surgery. However, surgery is not required before every fertility treatment. The decision should depend on symptoms, imaging findings, age and whether treating the condition is likely to improve reproductive health or treatment planning.
11. Greater Attention to Male Fertility
Fertility care is no longer viewed only as a woman’s responsibility. Male factors may contribute independently or together with female factors.
Early semen analysis can help avoid delays and allow both partners to be evaluated at the same stage. Depending on the findings, recommendations may involve lifestyle changes, medical treatment, surgery, IUI, IVF or ICSI.
Couples should avoid beginning prolonged treatment for one partner without completing an appropriate assessment of the other.
12. Emotional Support and Patient-Centred Care
Fertility testing and treatment can create emotional, physical and financial stress. Patient-centred care considers the couple’s emotional well-being, preferences, cultural values and treatment capacity alongside medical findings. Clear explanations, realistic discussions about success rates, transparent costs and access to counselling can help patients make informed decisions. Couples should feel comfortable asking questions, expressing concerns and taking time to understand their options. Emotional support from partners, family members, support groups or qualified counsellors can make the treatment journey more manageable.
Are All New Fertility Add-Ons Beneficial?
Not every new fertility add-on is necessary or proven to improve the likelihood of a live birth for every patient. Some techniques may benefit carefully selected cases, while evidence for others may be limited, uncertain or still developing. Before accepting an add-on, patients should ask what problem it addresses, why it is suitable for them, whether it improves clinically meaningful outcomes and what risks or additional costs are involved. A treatment should be selected because it meets a specific medical need—not simply because it is advertised as the newest technology.
When Should You Consult a Fertility Specialist?
Consider seeking medical advice if pregnancy has not occurred after 12 months of regular, unprotected intercourse. Earlier evaluation may be appropriate for women aged 35 or above, or when there are irregular periods, previous pelvic surgery, recurrent pregnancy loss, suspected endometriosis, known reproductive problems or male-factor concerns.
An early consultation does not necessarily mean that IVF will be advised. Some couples may benefit from simpler treatments after the underlying cause is identified.
Consult Dr. Sachin Dalal
Dr. Sachin Dalal provides evaluation and personalised guidance for women and couples experiencing fertility concerns. Treatment recommendations are made after reviewing the patient’s medical history, investigations, age and reproductive goals.
Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup Advanced Fertility Treatment in Bhandup